Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
Clinical trial NCT05372718 · RECRUITING
Trial details
- NCT number
- NCT05372718
- Sponsor
- Supergene, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-26
- Primary completion
- 2026-12-31
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.